Back to Search
Start Over
Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome
- Source :
- Chinese Medical Journal, Vol 135, Iss 22, Pp 2747-2749 (2022)
- Publication Year :
- 2022
- Publisher :
- Wolters Kluwer, 2022.
- Subjects :
- Medicine
Subjects
Details
- Language :
- English
- ISSN :
- 03666999, 25425641, and 00000000
- Volume :
- 135
- Issue :
- 22
- Database :
- Directory of Open Access Journals
- Journal :
- Chinese Medical Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.bd568f09ec134f99805631bfb23b987f
- Document Type :
- article
- Full Text :
- https://doi.org/10.1097/CM9.0000000000002503